As per Global Insight services’ assessment, about 5 prominent pharma and biotech giants are working on 5 drugs in the Uterine Fibroids – pipeline landscape globally. Uterine Fibroids Pipeline Insight, 2023” report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies:https://www.globalinsightservices.com/request-sample/GIS31215
Uterine fibroids are a common type of noncancerous tumor that can grow in and on your uterus. Uterine fibroids are found incidentally during a routine pelvic exam.
The causes of fibroids are unknown. Most fibroids happen in people of reproductive age. Possible causes include genetic changes, hormones, other growth factors and extracellular matrix.
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the treatment of Uterine Fibroids treatment such as Linzagolix, TU-2670, and others. Key players involved in the development of therapies to treat Uterine Fibroids are Kissei Pharmaceutical Co Ltd, TiumBio Co Ltd, and others. One drug is under Phase III clinical trials and one drug are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development. In Nov 2022, Tium Bio transferred the technology rights to China’s Hanso Pharmaceutical for China development of TU2670.
Report Highlights
Global Insight Service’s, Uterine Fibroids – Drug Pipeline Landscape, 2023 report provides an overview of the Uterine fibroids pipeline drugs. This report covers detailed insights on Uterine Fibroids drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Uterine Fibroids pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Key Players
Endo Pharm
Evestra Inc
Jiangsu HengRui Medicine Co., Ltd.
Kissei Pharmaceutical Co., Ltd.
Obseva
Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS31215
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like –
– Late-stage products (Phase III)
– Mid-stage products (Phase II)
– Early-stage product (Phase I)
– Pre-clinical and Discovery stage candidates
– Discontinued & Inactive candidates
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/